Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 20/20 | 0.69 |
| ▸ | ITGB6 | P18564 | 11/20 | 0.69 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.69 |
| ▸ | ITGB5 | P18084 | 7/20 | 0.69 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.69 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.69 |
| ▸ | ITGB8 | P26012 | 1/20 | 0.69 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL275079 | 0.91 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL5584347 | 0.91 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL12243894 | 0.88 | ITGAV (0.65) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL21713110 | 0.87 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL21713112 | 0.87 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL21744208 | 0.87 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL21744760 | 0.87 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL2446109 | 0.86 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| SCHEMBL2446101 | 0.86 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 | |
| Hydrochloric Acid SCHEMBL28556443 | 0.86 | ITGAV (0.69) | ITGAVITGB6ITGB3ITGB5ITGB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3613739-B1 | INTEGRIN ANTAGONISTS | Oxurion NV (BE) | 2020-11-04 | — | — | EP | disclosed |
| EP-3613739-A1 | INTEGRIN ANTAGONISTS | Oxurion NV (BE) | 2020-02-26 | — | — | EP | disclosed |